ORVILLE JACOB A 4

4 · EXACT SCIENCES CORP · Filed Feb 26, 2025

Form 4

Period: 2025-02-24

EVP, GM, Screening

Transactions

Tax Payment
Common Stock
2025-02-25$51.28/sh−1,859$95,330→ 20,277 total
Award
Restricted Stock Units
2025-02-24+28,779→ 28,779 total
→ Common Stock (28,779 underlying)
Exercise/Conversion
Common Stock
2025-02-25+3,954→ 22,136 total
Exercise/Conversion
Restricted Stock Units
2025-02-25−3,954→ 3,955 total
→ Common Stock (3,954 underlying)

Holdings

Footnotes (6)

[F1]Represents shares of common stock received upon vesting of a restricted stock unit award.
[F2]Represents shares of Common Stock retained by Exact Sciences Corporation for tax withholding purposes in connection with the net-settlement on the issuance of shares of Common Stock in respect to the vesting of certain restricted stock units.
[F3]In addition to the shares of Common Stock reported on this Form 4, which total 21,767 shares, Mr. Orville also holds, in the aggregate, an additional 94,684 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
[F4]Each restricted stock unit represents a contingent right to receive one share of common stock.
[F5]These restricted stock units vest in four equal annual installments beginning on February 27, 2026.
[F6]Represents a restricted stock unit award granted on February 25, 2022 that vests in four equal annual installments from the grant date.

Documents

1 file